Founded in 2015 at MIT by three physicists, XtalPi is the HKEX 18C inaugural listed tech leader (HKEX:2228) revolutionizing biopharmaceutical innovation through cutting-edge AI technology—delivering breakthroughs in small molecule drug development, including molecular glue platforms, and driving global access to life-changing therapies. With a proven track record of merging AI with precision science, we’re redefining how drugs are discovered, dev...
